Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Academia

August 10, 2009 | A version of this story appeared in Volume 87, Issue 32

Stephen Fesik has joined Vanderbilt University Medical Center as professor of biochemistry. He will lead the cancer drug discovery initiatives of the Vanderbilt Institute of Chemical Biology and the Vanderbilt-Ingram Cancer Center. Fesik had been a divisional vice president of cancer research at Abbott Laboratories, building a pipeline of drug candidates showing promising anticancer activity.

Susan J. Ainsworth compiles this section. Announcements of promotions, new hires, and retirements may be sent to s_ainsworth@acs.org.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.